Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
基本信息
- 批准号:10543076
- 负责人:
- 金额:$ 58.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-12-21 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcuteAfrica South of the SaharaAnabolismAntibiotic TherapyB-LymphocytesBacteriaCell Cycle ArrestCell DeathCell NucleusCellsCessation of lifeChildChronicCommunicable DiseasesComplexCytoplasmDNA DamageDataDevelopmentDisease OutbreaksEndocytosisEnvironmentEnzymesEtiologyExotoxinsGram-Negative BacteriaHumanInfectionIntegration Host FactorsInterventionKnowledgeLeukopeniaLymphocyteMacrophageMaintenanceMediatingMembraneModelingModificationMolecularMono(ADP-Ribose) TransferasesMulti-Drug ResistanceOrganPenetrationPersonsPolysaccharidesProteinsRecording of previous eventsRegulationResearchRoleSalmonellaSalmonella paratyphiSalmonella typhiSeriesSoutheastern AsiaStructureT-LymphocyteTestingToxinTyphoid FeverVaccinationVacuoleVi capsular polysaccharideVirulence Factorsacute infectionchronic infectionefficacious interventionexperimental studyextensive drug resistanceextracellularglobal healthholotoxinshumanized mouselow and middle-income countriesmouse modelmutantneutrophilnovelnovel strategiesnucleasepathogenpreventprogramsreceptor bindingreceptor mediated endocytosissuccesstraffickingtransmission processvesicle transport
项目摘要
PROJECT SUMMARY/ABSTRACT
Typhoid fever is one of the most successful and devastating infectious diseases in human history and remains
a serious real-world problem that kills 0.2 million and sickens 21 million people every year. The etiological agent
of typhoid fever is the gram-negative bacterium Salmonella enterica serovar Typhi (S. Typhi), which is adapted
solely to humans. S. Typhi’s persistent-carriage infection state, exemplified by “Typhoid Mary,” is critical for
person-to-person transmission and the continued maintenance of the bacterium within humans. If we are to
effectively contain and eradicate typhoid fever, we need to implement strategies inhibiting S. Typhi’s transition
to the persistent infection state. First, however, we must understand how S. Typhi facilitates transition from acute
to a persistent/carriage infection state. In a humanized mouse model that serves as a S. Typhi’s persistent
infection model, typhoid toxin, a distinct A2B5 toxin or exotoxin produced by intracellular S. Typhi, has been
identified as a critical bacterial determinant facilitating the transition of S. Typhi infection to the persistent-carriage
infection state. In this R01, we propose a series of experiments to better understand the typhoid toxin-mediated
host cell interactive mechanism promoting S. Typhi’s persistent infection. The proposed research may provide
critical information for the development of efficacious intervention strategies to better control S. Typhi’s
transmission and outbreaks.
项目概要/摘要
伤寒是人类历史上最成功和最具破坏性的传染病之一,并且仍然存在
这是一个严重的现实问题,每年导致 20 万人死亡、2100 万人患病。
伤寒的病原体是革兰氏阴性细菌肠沙门氏菌伤寒血清型(S. Typhi),它适应于
仅对人类来说,伤寒沙门氏菌的持续感染状态(以“伤寒玛丽”为例)对于人类来说至关重要。
如果我们愿意的话,人与人之间的传播以及细菌在人体内的持续存在。
为了有效遏制和根除伤寒,我们需要实施抑制伤寒沙门氏菌转变的策略
然而,首先,我们必须了解伤寒沙门氏菌如何促进急性感染状态的转变。
在作为伤寒沙门氏菌持续感染的人源化小鼠模型中。
感染模型,伤寒毒素,一种由细胞内伤寒沙门氏菌产生的独特 A2B5 毒素或外毒素,已被
被确定为促进伤寒沙门氏菌感染向持续携带转变的关键细菌决定因素
在这个R01中,我们提出了一系列实验来更好地了解伤寒毒素介导的情况。
拟议的研究可能提供促进伤寒沙门氏菌持续感染的宿主细胞相互作用机制。
制定有效干预策略以更好地控制伤寒沙门氏菌的关键信息
传播和爆发。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Direct IgG epitope mapping on bacterial AB toxins by cryo-EM.
- DOI:10.1016/j.xpro.2021.100852
- 发表时间:2021-12-17
- 期刊:
- 影响因子:0
- 作者:Nguyen T;Song J
- 通讯作者:Song J
Complete Genome Sequence of Salmonella enterica Serovar Typhi Strain ISP2825.
- DOI:10.1128/mra.00804-21
- 发表时间:2021-10-14
- 期刊:
- 影响因子:0.8
- 作者:Lee GY;Song J
- 通讯作者:Song J
Neutralization of Typhoid Toxin by Alpaca-Derived, Single-Domain Antibodies Targeting the PltB and CdtB Subunits.
- DOI:10.1128/iai.00515-21
- 发表时间:2022-02-17
- 期刊:
- 影响因子:3.1
- 作者:Dulal HP;Vance DJ;Neupane DP;Chen X;Tremblay JM;Shoemaker CB;Mantis NJ;Song J
- 通讯作者:Song J
Enteric Fever Diagnosis: Current Challenges and Future Directions.
- DOI:10.3390/pathogens10040410
- 发表时间:2021-04-01
- 期刊:
- 影响因子:0
- 作者:Neupane DP;Dulal HP;Song J
- 通讯作者:Song J
Malnutrition and maternal vaccination against typhoid toxin.
- DOI:10.1371/journal.ppat.1010731
- 发表时间:2022-08
- 期刊:
- 影响因子:6.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeongmin Song其他文献
Jeongmin Song的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeongmin Song', 18)}}的其他基金
Cracking Salmonella Typhis Secret Code: Understanding Pathogenic Mechanisms of Salmonella Typhi Toxin
破解伤寒沙门菌密码:了解伤寒沙门菌毒素的致病机制
- 批准号:
10164712 - 财政年份:2018
- 资助金额:
$ 58.14万 - 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
- 批准号:
10425840 - 财政年份:2018
- 资助金额:
$ 58.14万 - 项目类别:
Cracking Salmonella Typhis Secret Code: Understanding Pathogenic Mechanisms of Salmonella Typhi Toxin
破解伤寒沙门菌密码:了解伤寒沙门菌毒素的致病机制
- 批准号:
10404508 - 财政年份:2018
- 资助金额:
$ 58.14万 - 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
- 批准号:
9762253 - 财政年份:2018
- 资助金额:
$ 58.14万 - 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
- 批准号:
10308674 - 财政年份:2018
- 资助金额:
$ 58.14万 - 项目类别:
Typhoid Vaccines Targeting Both Salmonella Typhi and Its Secreted Virulence Factor
针对伤寒沙门氏菌及其分泌的毒力因子的伤寒疫苗
- 批准号:
10403451 - 财政年份:2018
- 资助金额:
$ 58.14万 - 项目类别:
Typhoid Vaccines Targeting Both Salmonella Typhi and Its Secreted Virulence Factor
针对伤寒沙门氏菌及其分泌的毒力因子的伤寒疫苗
- 批准号:
10160775 - 财政年份:2018
- 资助金额:
$ 58.14万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 58.14万 - 项目类别:
Does treating low density malaria infections reduce malaria transmission?
治疗低密度疟疾感染是否可以减少疟疾传播?
- 批准号:
10574796 - 财政年份:2023
- 资助金额:
$ 58.14万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 58.14万 - 项目类别:
Enhancing Research capacity for Sickle Cell Disease and related NCDs across the Lifespan in Uganda. ''Enrich Project''
加强乌干达全生命周期镰状细胞病和相关非传染性疾病的研究能力。
- 批准号:
10665128 - 财政年份:2023
- 资助金额:
$ 58.14万 - 项目类别:
Leveraging Data Science Applications to Improve Children's Environmental Health in Sub-Saharan Africa (DICE)
利用数据科学应用改善撒哈拉以南非洲儿童的环境健康 (DICE)
- 批准号:
10714773 - 财政年份:2023
- 资助金额:
$ 58.14万 - 项目类别: